Literature DB >> 32008854

Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.

Lynn van Olst1, Daan Verhaege2, Marc Franssen3, Alwin Kamermans3, Bart Roucourt4, Sofie Carmans4, Ellen Ytebrouck4, Susanne M A van der Pol3, Dennis Wever3, Marko Popovic3, Roosmarijn E Vandenbroucke5, Tomás Sobrino6, Marijn Schouten3, Helga E de Vries7.   

Abstract

Alzheimer's disease, progressive supranuclear palsy and frontotemporal dementia are characterized by neuronal expression of aberrant tau protein, tau hyperphosphorylation (pTAU), tau aggregation and neurofibrillary tangle formation sequentially culminating into neuronal cell death, a process termed tauopathy. Our aim was to address at which tauopathy stage neuroinflammation starts and to study the related microglial phenotype. We used Thy1-hTau.P301S (PS) mice expressing human tau with a P301S mutation specifically in neurons. Significant levels of cortical pTAU were present from 2 months onwards. Dystrophic morphological complexity of cortical microglia arose after pTAU accumulation concomitant with increased microglial lysosomal volumes and a significant loss of homeostatic marker Tmem119. Interestingly, we detected increases in neuronal pTAU and postsynaptic structures in the lysosomes of PS microglia. Moreover, the overall cortical postsynaptic density was decreased in 6-month-old PS mice. Together, our results indicate that microglia adopt a pTAU-associated phenotype, and are morphologically and functionally distinct from wild-type microglia after neuronal pTAU accumulation has initiated.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; FTD; Hyperphosphorylated tau; Microglia; P301S; Synapses

Mesh:

Substances:

Year:  2020        PMID: 32008854     DOI: 10.1016/j.neurobiolaging.2020.01.003

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  20 in total

Review 1.  Microglia: Friend and foe in tauopathy.

Authors:  Kristian F Odfalk; Kevin F Bieniek; Sarah C Hopp
Journal:  Prog Neurobiol       Date:  2022-06-14       Impact factor: 10.885

2.  Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration.

Authors:  Maud Gratuze; Cheryl Eg Leyns; Andrew D Sauerbeck; Marie-Kim St-Pierre; Monica Xiong; Nayeon Kim; Javier Remolina Serrano; Marie-Ève Tremblay; Terrance T Kummer; Marco Colonna; Jason D Ulrich; David M Holtzman
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

3.  Dystrophic microglia are associated with neurodegenerative disease and not healthy aging in the human brain.

Authors:  Ryan K Shahidehpour; Rebecca E Higdon; Nicole G Crawford; Janna H Neltner; Eseosa T Ighodaro; Ela Patel; Douglas Price; Peter T Nelson; Adam D Bachstetter
Journal:  Neurobiol Aging       Date:  2021-01-07       Impact factor: 4.673

Review 4.  Microglia in Alzheimer's Disease in the Context of Tau Pathology.

Authors:  Juan Ramón Perea; Marta Bolós; Jesús Avila
Journal:  Biomolecules       Date:  2020-10-14

5.  Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer's disease-related pathologies in a senescence-accelerated mouse model.

Authors:  Ju Wang; Hui-Jie Hu; Zi-Kai Liu; Jing-Jing Liu; Shan-Shan Wang; Qing Cheng; Hong-Zhuan Chen; Mingke Song
Journal:  Transl Neurodegener       Date:  2021-03-31       Impact factor: 8.014

6.  Chronic Intermittent Hypoxia Enhances Pathological Tau Seeding, Propagation, and Accumulation and Exacerbates Alzheimer-like Memory and Synaptic Plasticity Deficits and Molecular Signatures.

Authors:  Syed Faraz Kazim; Abhijeet Sharma; Sivaprakasam R Saroja; Joon Ho Seo; Chloe S Larson; Aarthi Ramakrishnan; Minghui Wang; Robert D Blitzer; Li Shen; Catherine J Peña; John F Crary; Larissa A Shimoda; Bin Zhang; Eric J Nestler; Ana C Pereira
Journal:  Biol Psychiatry       Date:  2021-03-24       Impact factor: 13.382

7.  Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer's disease.

Authors:  Ceren Emre; Khanh V Do; Bokkyoo Jun; Erik Hjorth; Silvia Gómez Alcalde; Marie-Audrey I Kautzmann; William C Gordon; Per Nilsson; Nicolas G Bazan; Marianne Schultzberg
Journal:  Acta Neuropathol Commun       Date:  2021-06-29       Impact factor: 7.801

8.  Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice.

Authors:  Tao Yang; Harry Liu; Kevin C Tran; Albert Leng; Stephen M Massa; Frank M Longo
Journal:  Acta Neuropathol Commun       Date:  2020-09-05       Impact factor: 7.801

9.  Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration.

Authors:  Ione O C Woollacott; Christina E Toomey; Catherine Strand; Robert Courtney; Bridget C Benson; Jonathan D Rohrer; Tammaryn Lashley
Journal:  J Neuroinflammation       Date:  2020-08-10       Impact factor: 8.322

Review 10.  Deleterious Alteration of Glia in the Brain of Alzheimer's Disease.

Authors:  Eunyoung Kim; Undarmaa Otgontenger; Ariunzaya Jamsranjav; Sang Seong Kim
Journal:  Int J Mol Sci       Date:  2020-09-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.